RAPT Therapeutics to Participate in Upcoming Investor Conferences
Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
RAPT Therapeutics (NASDAQ: RAPT), a clinical-stage biopharmaceutical company specializing in immunology-based therapies, has announced its participation in two major investor conferences in June 2025. The company's management will present at the Goldman Sachs 46th Annual Global Healthcare Conference, delivering a fireside chat on June 10, 2025, at 9:20 a.m. ET. Additionally, they will conduct one-on-one investor meetings at the UBS Spring Biotech Conference on June 24, 2025. Investors can access the Goldman Sachs fireside chat webcast live or as a recording through RAPT Therapeutics' investor relations website.
RAPT Therapeutics (NASDAQ: RAPT), un'azienda biofarmaceutica in fase clinica specializzata in terapie basate sull'immunologia, ha annunciato la sua partecipazione a due importanti conferenze per investitori nel giugno 2025. Il management dell'azienda presenterà alla 46ª Conferenza Globale Annuale sulla Sanità di Goldman Sachs, tenendo un incontro informale il 10 giugno 2025 alle 9:20 ET. Inoltre, svolgeranno incontri individuali con investitori durante la Conferenza UBS Spring Biotech il 24 giugno 2025. Gli investitori potranno seguire la diretta streaming o la registrazione dell'incontro informale di Goldman Sachs tramite il sito web delle relazioni con gli investitori di RAPT Therapeutics.
RAPT Therapeutics (NASDAQ: RAPT), una empresa biofarmacéutica en etapa clínica especializada en terapias basadas en inmunología, ha anunciado su participación en dos importantes conferencias para inversores en junio de 2025. La dirección de la empresa presentará en la 46ª Conferencia Global Anual de Salud de Goldman Sachs, ofreciendo una charla informal el 10 de junio de 2025 a las 9:20 a.m. ET. Además, realizarán reuniones individuales con inversores en la Conferencia UBS Spring Biotech el 24 de junio de 2025. Los inversores podrán acceder a la retransmisión en vivo o a la grabación de la charla informal de Goldman Sachs a través del sitio web de relaciones con inversores de RAPT Therapeutics.
임상 단계의 면역학 기반 치료제 전문 바이오제약 회사인 RAPT Therapeutics(NASDAQ: RAPT)는 2025년 6월에 열리는 두 개의 주요 투자자 컨퍼런스에 참여한다고 발표했습니다. 회사 경영진은 2025년 6월 10일 오전 9시 20분(동부시간)에 열리는 골드만삭스 제46회 연례 글로벌 헬스케어 컨퍼런스에서 파이어사이드 채팅을 진행할 예정입니다. 또한 2025년 6월 24일 UBS 스프링 바이오텍 컨퍼런스에서 1:1 투자자 미팅을 가질 예정입니다. 투자자들은 RAPT Therapeutics 투자자 관계 웹사이트를 통해 골드만삭스 파이어사이드 채팅을 실시간 또는 녹화 영상으로 시청할 수 있습니다.
RAPT Therapeutics (NASDAQ : RAPT), une société biopharmaceutique en phase clinique spécialisée dans les thérapies basées sur l'immunologie, a annoncé sa participation à deux grandes conférences pour investisseurs en juin 2025. La direction de l'entreprise présentera lors de la 46e conférence mondiale annuelle sur la santé de Goldman Sachs, avec une discussion informelle prévue le 10 juin 2025 à 9h20 (heure de l'Est). De plus, elle tiendra des réunions individuelles avec des investisseurs lors de la conférence UBS Spring Biotech le 24 juin 2025. Les investisseurs pourront accéder à la diffusion en direct ou à l'enregistrement de la discussion informelle de Goldman Sachs via le site web des relations investisseurs de RAPT Therapeutics.
RAPT Therapeutics (NASDAQ: RAPT), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf immunologische Therapien spezialisiert hat, hat seine Teilnahme an zwei wichtigen Investorenkonferenzen im Juni 2025 angekündigt. Das Management des Unternehmens wird auf der 46. jährlichen Global Healthcare Conference von Goldman Sachs am 10. Juni 2025 um 9:20 Uhr ET einen Fireside Chat halten. Außerdem werden Einzelgespräche mit Investoren auf der UBS Spring Biotech Conference am 24. Juni 2025 stattfinden. Investoren können den Fireside Chat von Goldman Sachs live oder als Aufzeichnung über die Investor-Relations-Website von RAPT Therapeutics verfolgen.
Positive
- None.
Negative
- None.
SOUTH SAN FRANCISCO, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that members of the RAPT management team will participate in the following investor conferences in June:
- Goldman Sachs 46th Annual Global Healthcare Conference – Fireside chat on Tuesday, June 10, 2025 at 9:20 a.m. ET
- UBS Spring Biotech Conference – Investor one-on-one meetings on Tuesday, June 24, 2025
To access the live webcast or subsequent archived recording of the Goldman Sachs fireside chat, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.
About RAPT Therapeutics, Inc.
RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases. Utilizing our deep and proprietary expertise in immunology, we develop novel therapies that are designed to modulate the critical immune responses underlying these diseases.
RAPT Investor Contact:
Sylvia Wheeler
swheeler@wheelhouselsa.com
RAPT Media Contact:
Aljanae Reynolds
areynolds@wheelhouselsa.com
FAQ
When is RAPT Therapeutics presenting at the Goldman Sachs Healthcare Conference 2025?
RAPT Therapeutics will present a fireside chat at the Goldman Sachs Healthcare Conference on Tuesday, June 10, 2025 at 9:20 a.m. ET.
Which investor conferences is RAPT Therapeutics (RAPT) attending in June 2025?
RAPT Therapeutics is attending two conferences: the Goldman Sachs 46th Annual Global Healthcare Conference and the UBS Spring Biotech Conference.
How can investors access RAPT Therapeutics' Goldman Sachs conference presentation?
Investors can access the live webcast or archived recording of the fireside chat through RAPT Therapeutics' website at investors.rapt.com/events-and-presentations.
What type of meetings will RAPT have at the UBS Spring Biotech Conference?
RAPT Therapeutics will conduct one-on-one investor meetings at the UBS Spring Biotech Conference on June 24, 2025.
Rapt Therapeutics, Inc.
NASDAQ:RAPT
RAPT Rankings
RAPT Latest News
RAPT Stock Data
128.70M
101.65M
0.49%
96.43%
1.99%
Biotechnology
Pharmaceutical Preparations
United States
SOUTH SAN FRANCISCO